Insider Stock Trading History of Barlow David S


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Barlow David S since year 2005. The trader's CIK number is 1299065. At the time of this reporting, Barlow David S is the Director of Molecular Insight Pharmaceuticals, Inc. . (stock ticker symbol MIPI). See this page for all insider trading activities at Molecular Insight Pharmaceuticals, Inc. .

Note that in the past Barlow David S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Barlow David S since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2011-01-27 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 38,000 .18 6,650
2011-01-28 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 59,000 .16 9,381
2010-12-17 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 155,000 .20 31,000
2010-12-16 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 45,000 .22 9,900
2010-01-12 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 4,000 2.08 8,308
2010-01-14 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 5,800 1.99 11,536
2009-12-18 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 5,500 2.26 12,402
2009-12-21 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 6,300 2.33 14,704
2009-12-23 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 13,500 2.36 31,914
2009-12-24 MIPI Molecular Insight Pharmaceuticals, Inc. Sale 2,000 2.34 4,680
2008-12-29 MIPI Molecular Insight Pharmaceuticals, Inc. Option Ex 81,249 3.60 292,496
2007-11-30 MIPI Molecular Insight Pharmaceuticals, Inc. Buy 5,000 8.47 42,355
2007-11-20 MIPI Molecular Insight Pharmaceuticals, Inc. Buy 15,000 6.77 101,565
2007-11-08 MIPI Molecular Insight Pharmaceuticals, Inc. Option Ex 75,001 3.60 270,003
2007-01-03 NRPH New River Pharmaceuticals Inc Sale 10,000 54.83 548,310
2007-01-03 NRPH New River Pharmaceuticals Inc Option Ex 10,000 3.34 33,350
2006-12-01 NRPH New River Pharmaceuticals Inc Sale 10,000 49.01 490,090
2006-12-01 NRPH New River Pharmaceuticals Inc Option Ex 10,000 3.34 33,350
2006-03-20 NRPH New River Pharmaceuticals Inc Option Ex 10,000 3.34 33,350
2006-03-20 NRPH New River Pharmaceuticals Inc Sale 10,000 30.86 308,570

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barlow David S (Director of Molecular Insight Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.